Deal of the week: Talecris Biotherapeutics

Talecris sells for $3.1B, which represents a 22x for investors

18 August 2008•1 min read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.